积极水化预防急性心肌梗死直接PCI后肾损伤的随机临床试验
该多中心开放标签随机对照试验纳入560例接受直接PCI的STEMI患者,比较积极水化与一般水化对对比剂急性肾损伤(CI-AKI)的预防效果。最终分析469例,积极水化组CI-AKI发生率显著低于一般水化组(21.8% vs 31.1%,RR 0.70,95%CI 0.52-0.96),急性心衰发生率无显著差异。
要点
- 积极水化可降低STEMI患者直接PCI后CI-AKI风险(RR 0.70)。
- 积极水化未显著增加急性心衰发生率(8.1% vs 6.4%)。
- 男性、肾功能不全及非前壁心梗患者获益更明显。
核心结论
- 与一般水化相比,围术期积极水化在STEMI直接PCI患者中预防CI-AKI似乎安全有效。
研究设计与样本
- 多中心(中国15家教学医院)开放标签随机对照试验,共560例成人患者随机1:1分配,最终469例纳入分析。
主要发现
- 积极水化组CI-AKI发生率为21.8%,一般水化组为31.1%(RR 0.70,95%CI 0.52-0.96)。
- 急性心衰发生率积极水化组8.1%,一般水化组6.4%(RR 1.13,95%CI 0.66-2.44)。
- 亚组分析显示男性、肾功能不全及非前壁心梗患者中积极水化预防CI-AKI效果更好。
关键数值与推荐
- CI-AKI定义:直接PCI后48-72小时内血清肌酐较基线升高>25%或0.5 mg/dL。
- 积极水化方案:术前30分钟内给予125/250 mL生理盐水负荷,术后在左室舒张末期压指导下水化4小时,并额外水化至PCI后24小时。
- 一般水化方案:随机化后6小时内以1 mL/kg/小时速度给予≤500 mL 0.9%盐水。
临床怎么用
- 对于接受直接PCI的STEMI患者,可考虑围术期积极水化以降低CI-AKI风险,但需监测心衰迹象。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the efficacy of aggressive hydration compared with general hydration for contrast-induced acute kidney injury (CI-AKI) prevention among patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI). METHODS: The Aggressive hydraTion in patients with STEMI undergoing pPCI to prevenT Contrast-Induced Acute Kidney Injury study is an open-label, randomised controlled study at 15 teaching hospitals in China. A total of 560 adult patients were randomly assigned (1:1) to receive aggressive hydration or general hydration treatment. Aggressive hydration group received preprocedural loading dose of 125/250 mL normal saline within 30 min, followed by postprocedural hydration performed for 4 hours under left ventricular end-diastolic pressure guidance and additional hydration until 24 hours after pPCI. General hydration group received ≤500 mL 0.9% saline at 1 mL/kg/hour for 6 hours after randomisation. The primary end point is CI-AKI, defined as a >25% or 0.5 mg/dL increased in serum creatinine from baseline during the first 48-72 hours after primary angioplasty. The safety end point is acute heart failure. RESULTS: From July 2014 to May 2018, 469 patients were enrolled in the final analysis. CI-AKI occurred less frequently in aggressive hydration group than in general hydration group (21.8% vs 31.1%; risk ratio (RR) 0.70, 95% CI 0.52 to 0.96). Acute heart failure did not significantly differ between the aggressive hydration group and the general hydration group (8.1% vs 6.4%, RR 1.13, 95% CI 0.66 to 2.44). Several subgroup analysis showed the better effect of aggressive hydration in CI-AKI prevention in male, renal insufficient and non-anterior myocardial infarction participants. CONCLUSIONS: Comparing with general hydration, the peri-operative aggressive hydration seems to be safe and effective in preventing CI-AKI among patients with STEMI undergoing pPCI.
引用
- Liu Y, Tan N, Huo Y, et al. Hydration for prevention of kidney injury after primary coronary intervention for acute myocardial infarction: a randomised clinical trial. Heart. 2022. PMID: 34509996. doi:10.1136/heartjnl-2021-319716
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。